Granite Point Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-43,195	Closed	-$78K	–	136
2018 Q2	$78K	Sell	43,195 -98,594	-70%	-$198K	0.04%	116
2018 Q1	$334K	Sell	141,789 -120,587	-46%	-$283K	0.21%	91
2017 Q4	$494K	Buy	262,376 +211,455	+415%	+$462K	0.27%	80
2017 Q3	$127K	Hold	50,921	–	–	0.08%	95
2017 Q2	$140K	Sell	50,921 -27,080	-35%	-$75.7K	0.09%	99
2017 Q1	$235K	Sell	78,001 -12,058	-13%	-$34.2K	0.16%	78
2016 Q4	$284K	Hold	90,059	–	–	0.25%	71
2016 Q3	$307K	Hold	90,059	–	–	0.25%	80
2016 Q2	$206K	Buy	+90,059	New	+$221K	0.19%	77
2015 Q4	$346K	Hold	104,687	–	–	0.3%	72
2015 Q3	$253K	Sell	104,687 -4,817	-4%	-$12.5K	0.24%	78
2015 Q2	$321K	Sell	109,504 -32,982	-23%	-$128K	0.24%	85
2015 Q1	$572K	Hold	142,486	–	–	0.41%	69
2014 Q4	$429K	Buy	+142,486	New	+$385K	0.4%	67